L C Chen

Summary

Affiliation: University of Manchester
Country: UK

Publications

  1. ncbi request reprint Systematic review of the analgesic efficacy and tolerability of COX-2 inhibitors in post-operative pain control
    L C Chen
    Drug Usage and Pharmacy Practice Group, School of Pharmacy and Pharmaceutical Sciences, The University of Manchester, Oxford Road, Manchester M13 9PL, UK
    J Clin Pharm Ther 29:215-29. 2004
  2. ncbi request reprint Do selective COX-2 inhibitors increase the risk of cerebrovascular events? A meta-analysis of randomized controlled trials
    L C Chen
    School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Oxford Road, Manchester, M13 9PL, UK
    J Clin Pharm Ther 31:565-76. 2006
  3. ncbi request reprint Topical pimecrolimus for eczema
    D M Ashcroft
    University of Manchester, School of Pharmacy and Pharmaceutical Sciences, 1st Floor, Stopford Building, Oxford Road, Manchester, UK, M13 9PT
    Cochrane Database Syst Rev . 2007

Detail Information

Publications3

  1. ncbi request reprint Systematic review of the analgesic efficacy and tolerability of COX-2 inhibitors in post-operative pain control
    L C Chen
    Drug Usage and Pharmacy Practice Group, School of Pharmacy and Pharmaceutical Sciences, The University of Manchester, Oxford Road, Manchester M13 9PL, UK
    J Clin Pharm Ther 29:215-29. 2004
    ..To evaluate the relative analgesic efficacy and tolerability of single-dose COX-2 inhibitors in post-operative pain management...
  2. ncbi request reprint Do selective COX-2 inhibitors increase the risk of cerebrovascular events? A meta-analysis of randomized controlled trials
    L C Chen
    School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Oxford Road, Manchester, M13 9PL, UK
    J Clin Pharm Ther 31:565-76. 2006
    ..To evaluate the risk of cerebrovascular events (CVEs) associated with selective cyclooxygenase-2 inhibitors (coxibs)...
  3. ncbi request reprint Topical pimecrolimus for eczema
    D M Ashcroft
    University of Manchester, School of Pharmacy and Pharmaceutical Sciences, 1st Floor, Stopford Building, Oxford Road, Manchester, UK, M13 9PT
    Cochrane Database Syst Rev . 2007
    ..Pimecrolimus was developed as an alternative to topical corticosteroids for treating eczema (atopic dermatitis) but its efficacy and safety compared with existing treatments remains unclear...